Quality assurance in semen analysis has been questioned recently in this journal. Based on the limited capacity of seminal parameter in the determination of fertility, the authors advocated abandoning methods of quality assurance in semen analysis for clinical situations. In this article, we explore arguments as to why quality assurance in semen analysis for clinical use is not 'a waste of time'. Imprecision and within-subject biological variations are the two major components involved in the dispersion of seminal parameter results obtained by analysis of a semen sample from an individual. As within-subject biological variation is constant across geography, time and population, imprecision is a very important factor in the quality of laboratory test results. We analyse this influence on various seminal parameters and observe that there is an amount of error that can be tolerated without invalidating the medical usefulness of seminal parameter determination. However, there is a maximum allowable analytical error above which the medical usefulness of seminal parameter results is invalidated. The level of performance required to facilitate clinical decision-making is termed quality specification. We comment on different strategies to define the maximum allowable analytical error.
Introduction
For the correct interpretation of laboratory test results concerning an individual, it is necessary to consider analytical and biological variability. Understanding of this variability is an integral part of accurate clinical judgment in test interpretation. All too often the magnitude of a change is confused with the 'sensitivity' of that change. Jequier (2005) has stated that only extreme numerical changes can be used to make a reasonably accurate prognosis (i.e. semen analysis in the determination of fertility), the influence of analytical variability on the results is small; this overlooks the fact that such an influence depends on the inherent biological variation around the homeostatic setting point (within-subject biological variation) of the biological parameter. Andrology laboratories must provide the information required by clinicians for the correct interpretation and use of semen analysis results.
Imprecision
Random analytical error is a very important factor in the quality of test results. The quantitative estimate of random analytical error is termed imprecision, this being defined as the closeness of agreement between independent results of measurements obtained under stipulated conditions. Laboratories can determine imprecision by conducting replicate experiments in which the same material is analysed a given minimum of times according to National Committee for Clinical Laboratory Standards (1985) recommendations. The imprecision can then be quantified by calculating the standard deviation (SD) and the coefficient of variation [CV = 100 × (SD/mean)]. The percentage of dispersion of a result obtained by one analysis of a single sample from an individual is calculated from the formula:
where Z is the number of standard deviations appropriate to the probability selected: 1.96 for 95% (P < 0.05) for example, is the most commonly used Z-score.
Imprecision often varies according to the level of the analyte. In our experience, using World Health Organization (1999) guidelines for routine seminal analysis, analytical CV (CV a ) with different control materials and different seminal quality levels for seminal parameters ranged between 8 and 12% for concentration, 7-14% for progressive motility and 7-18% for morphology (Álvarez et al., 2003) . These results are similar to those reported by other authors (Neuwinger et al., 1990; Cooper et al., 1992 Let us assume that a result for sperm concentration is reported as 35 × 10 6 /ml. Supposing zero analytical bias, if CV a at a concentration of 35 × 10 6 /ml is 10% (similar to the value described previously by us; Álvarez et al., 2003) , then we are 95% confident that the sperm concentration of that specimen lies between 28 and 42 × 10 6 /ml (±19.6%). If the laboratory has a CV a of 20%, the 95% confidence interval at a concentration of 35 × 10 6 /ml is 21 and 49 × 10 6 /ml (±39.2%). In the above example, given an individual with a true homeostatic setting point of 35 × 10 6 /ml, for the clinician's understanding of the patient's fertility potential it is the same to have a result of 21 × 10 6 /ml (low limit of 95% confidence interval with a CV a of 20%) as one of 49 × 10 6 /ml (high limit of 95% confidence interval with a CV a of 20%). We can accept a dispersion of results approximately less than ±40%. Therefore, Jequier (2005) is correct when she states: 'the accuracy of a sperm count does little to enhance the clinician's understanding of its fertility potential'. However, the statement by Jequier (2005) does not take into account that biological variation is a factor which must be kept in mind when a semen result is interpreted.
Biological variation
In the simplest and most widely used model, each analyte in an individual varies around the homeostatic setting point of that individual. This variation is assumed to be random in nature and therefore, like imprecision, can be expressed quantitatively as a statistic such as SD or CV. The generation and application of quantitative data on the components of biological variation (within-and between-subject biological coefficient of variation, CV Bw and CV Bb , respectively) has been addressed in detail by Fraser (2001) . We have reported (Álvarez et al., 2003) a study of components of biological variation of seminal parameters following the above-mentioned model. The model is based on healthy subjects, sperm donor candidate and strict protocol-controlled conditions (i.e. 3-4 days' abstinence, same period of study, same analytical procedure and same frequency per sample).
According to Fraser and Harris (1989) , the total random variation of a laboratory test result (CV t ) is the square root of the sum of the squares of the component variations Therefore, the percentage of dispersion of a result obtained by the analysis of a single sample from an individual is calculated from the formula:
Recalculating the above example, using the CV Bw for sperm concentration described by us (26.8%; Álvarez et al., 2003) , and a CV a of 10%, we obtain that 95% dispersion of the result is ±56.1%, equivalent to an interval of 15-55 for 35 × 10 /ml. It is unlikely, but possible, that a clinician might consider the same clinical decision with a result of 15 × 10 6 /ml as with 55 × 10 6 /ml. If we suppose a CV a of 20%, 95% dispersion of the result is ±65.5%, equivalent to an interval of 12-58 for 35 × 10 6 /ml. We believe that in this case, a clinician could take a different decision in an individual with a reported sperm concentration value of 12 × 10 6 /ml (low limit of 95% confidence interval with a CV a of 20%) than with a reported value of 58 × 10 6 /ml (high limit of 95% confidence interval with a CV a of 20%). For example, in a young couple who, in the absence of relevant pathology (tubal, andrological, endocrine, infectious or other seminal parameters), do not conceive within 3 years, a clinician could recommend directly ICSI or IVF (if the value reported is 12 × 10 6 /ml) or intrauterine insemination (if the value reported is 58 × 10 6 /ml). Using the Internet calculator of Fraser (2005) , it is shown in Figure 1 that the dispersion of seminal parameter results increases with the imprecision. Therefore, the effect of imprecision in the dispersion of the result is important, on the contrary to what was reported by Jequier (2005) .
Quality specification
In the above example, it was stated that there is a dispersion of results (<40%), which does not invalidate the medical usefulness of the sperm concentration result, and therefore that the CV a is acceptable. What amount of analytical error can be tolerated without invalidating the medical usefulness of sperm concentration determination? The level of performance required to facilitate clinical decision-making is termed the quality specification, and it is a prerequisite for instituting quality management. The maximum allowable analytical error can be defined by various strategies and these have been ordered hierarchically . Ideally, quality specifications should be derived objectively from an analysis of medical needs. Unfortunately, this is very difficult and the necessary calculations have been made for only a few analytes in a limited number of different clinical settings . Other strategies that have been recommended for determining quality specifications include professional recommendations (guidelines by national or international expert groups or by expert individuals or institutional groups), those established by regulation or by external quality assessment schemes (EQAS) or those derived from data on the state of the art. Quality specifications based on components of biological variation, within and between subjects, have been proposed by various professional groups (Fraser, 2001) . Cotlove et al. (1970) proposed that a desirable quality specification expressed as the analytical coefficient of variation for assays should be equal to or less than half of the within-subject biological coefficient of variation (<0.5CV Bw ). However, for assays that, with currently available techniques, could not easily meet this analytical goal, Fraser et al. (1997) suggested a minimum analytical goal expressed as the analytical coefficient of variation of <0.75CV Bw . For assays for which it is easy to meet desirable standards, the same authors suggested an optimum quality specification expressed as the analytical coefficient of variation of <0.25CV Bw .
We have reported (Álvarez et al., 2003) a study of analytical goals for semen parameters using the components of biological variation, following the above-mentioned recommendations of Fraser et al. (1997) (<0.75CV Bw ) . However, the lack of a standardized methodology used by those seeking to obtain the values of the components of biological variability, together with the fact that it is unclear whether biological variation components derived from healthy subjects can be extrapolated to pathological situations (Ricós et al., 1999) limit their use.
For all these reasons, it is necessary to obtain analytical goals from another model. The use of the state of the art has been proposed by many bodies, including the French Society of Clinical Biology (Vassault et al., 1999) and the Spanish Association of Analytic Pharmaceutics (Calafell et al., 2002) .
Comparison of analytical quality can be accomplished through reference to the performance achieved by the best laboratories participating in EQAS. This method was used by us to calculate quality specifications for the seminal parameter (Castilla et al., 2005) . In summary, there exist strategies for setting the amount of error, which will allow one to establish the quality of seminal parameter determination in andrology laboratories to assist clinicians in practising good medicine.
From our results (Castilla et al., 2005) , and from other authors (Keel, 2004) , we conclude that a significant number of laboratories need to improve the analytical quality achieved in semen analysis. Various approaches have been shown to have a positive impact on the quality of semen analysis: improvement of training (Franken et al., 2000; Björdahl et al., 2002; Franken et al., 2003) , implementing effective internal quality control (Cooper et al., 1992) and quality assurance programmes (Byrd, 1992) and participating in and evaluating the results of external quality control programmes (Cooper et al., 1999) .
How we can reduce the dispersion of results of a laboratory test?
As commented above, the dispersion of results depends on analytical and biological variations. Variation (as SD or CV) is reduced by the square root of the number of replicates. A general formula is , where n a is the number of replicate analyses performed on each sample and n s is the number of patient samples (Fraser, 2001) . From this, the number of samples required to obtain an estimate within a certain percentage of the true individual homeostatic setting point of the individual can be determined by the Internet calculator of Fraser (2005) , using the formula given by Fraser (2001): where D is the deviation in per cent from the true homeostatic set point that one would consider acceptable. Figure 2 shows that the percentage of dispersion from the true homeostatic setting point of seminal parameters is progressively less when we increase the number of samples analysed or the replicates of a sample tested. Reducing CV a even further through duplicate analyses has very little effect on the percentage of dispersion. However, since biological variation is larger than imprecision, taking replicate samples does not decrease the dispersion of the test result.
The number of semen samples required to obtain an estimate of the true individual homeostatic setting point of seminal parameters [concentration, total motility (grades a + b + c), progressive motility (grades a + b), rapid progressive motility (grade a), sperm morphology and vitality], according to the probability selected, is shown in Figure 3 . To obtain more precise estimations (D <15%) from the homeostatic setting point with a 95% probability, it is necessary to analyse 14 samples for seminal concentration; six for total motility, seven for morphology and three for vitality. To obtain an estimation with D <40% from the true homeostatic setting point with a 95% probability, it is sufficient to analyse two samples for all seminal parameters except for concentration, for which we must analyse three. Using this formula, Sergerie et al. (2005) recently calculated the number of tests needed to estimate the homeostatic setting point for sperm DNA fragmentation and reported that at 80% confidence three semen samples are required to obtain an estimate within ±20% of the true setting point. Traditionally, it is recommended in clinical practice that at least two semen samples should be analysed to estimate an individual's potential fertility (World Health Organization, 1999) . We consider this practice correct for sperm motility, morphology and vitality. However, for sperm concentration, three semen samples should be provided to estimate an individual's profile. A similar conclusion has been reached by other authors (Poland et al., 1985; Carlsen et al., 2004) . Jeyendran (2000) suggests that in order to obtain objective data, up to four ejaculates should be analysed.
In summary, an amount of analytical error in the seminal parameter determination is allowable without the clinical or investigating usefulness of the results being invalidated. As the biological variation of the seminal parameter is high, a very low CV a is unnecessary. However, there is a maximum allowable analytical error (quality specification), above which the medical usefulness of the seminal parameter result is invalidated. Since the biological variation of seminal parameters is high, to reduce the dispersion of the result it is more important to obtain multiple semen samples than to replicate the analysis of a given semen sample. Andrology laboratories should communicate to the clinician the effect of the imprecision and the biological variation in the results of the seminal parameter in order to facilitate an improved clinical interpretation of semen analysis as a fundamental step in the management of male infertility. We believe, like Fraser (2004) , that the calculations outlined here should be undertaken to practise evidence-based medicine. Figure 3 . Number of semen samples (y-axis) needed to obtain a percentage of deviation (x-axis) of the true individual homeostatic setting point of seminal parameters according to the probability selected (P < 0.05). 
